Tapentadol, Screen Only, Urine
Also known as: Nucynta®
Use
Drug analysis/clinical drug monitoring
Special Instructions
The test is intended for pain management purposes and is not suitable for workplace testing. Samples should be collected with urine temperature monitoring to ensure validity. It is important to maintain the sample at room temperature; if the sample's arrival at the lab will take more than seven days, it should be refrigerated.
Limitations
The test is for in vitro diagnostic use only and was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the FDA, thus it should be used as a preliminary unconfirmed analytical test. Results should be interpreted in the context of clinical information as various factors can affect test outcomes.
Methodology
Immunoassay (IA)
Biomarkers
LOINC Codes
- 72485-6
- 77202-0
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
20 mL
Minimum Volume
Not provided
Container
Plastic urine container
Collection Instructions
Urine temperature monitoring is recommended to ensure valid specimen collection.
Storage Instructions
Maintain specimen at room temperature. If arrival at lab will extend beyond seven days, refrigerate.
Causes for Rejection
Quantity not sufficient for analysis; incorrect specimen; incomplete specimen identification
Other tests from different labs that may be relevant